CHICAGO, February 6, 2019 –
- Omron HeartGuide™, the first wearable blood pressure device, will integrate with physIQ’s pinpointIQ® analytics platform to indicate a potential health risk
- This combined solution is being deployed to help manage recently-discharged, at-risk patients
- The goal is to provide clinicians with physiological insight to proactively address potential clinical deterioration
Omron Healthcare, Inc. and physIQ Inc.
today announced a collaboration to integrate Omron’s innovative FDA-cleared device, HeartGuide™, the first wearable blood pressure monitor into the pinpointIQ®
platform to monitor at-risk patients in an outpatient setting. The strategic collaboration aims to generate actionable clinical information for at-risk patients in an outpatient environment by leveraging the complementary technologies of each company. Omron is the global leader in personal heart health and wellness technology and physIQ is a pioneer in FDA-cleared Artificial Intelligence physiology analytics